comparemela.com

Latest Breaking News On - Helius medical technologies inc - Page 12 : comparemela.com

Helius Medical Technologies Announces Reverse Stock Split

Helius Medical Technologies Announces Reverse Stock Split
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lisam-wilson
Exchange-commission-on
Site-communications-inc
Nasdaq
Helius-medical-technologies-inc
Company-certificate-of-incorporation
Company-common-stock
Medical-technologies
Nasdaq-capital-market
Common-stock
Nasdaq-stock-market

Helius Medical Technologies (NASDAQ:HSDT) Issues Quarterly Earnings Results

Helius Medical Technologies (NASDAQ:HSDT) Issues Quarterly Earnings Results
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Helius-medical-technologies-inc
Securities-exchange-commission
Nasdaq
Helius-medical-technologies-company-profile
Renaissance-technologies
Helius-medical-technologies
Get-free-report
Medical-technologies
Free-report
Portable-neuromodulation-stimulator
Helius-medical-technologies-daily

Helius Medical Technologies (NASDAQ:HSDT) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Helius Medical Technologies (NASDAQ:HSDT – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.05, Zacks reports. The business had revenue of $0.26 million during the quarter, compared to the consensus estimate of $0.17 million. Helius […]

Nasdaq
Renaissance-technologies
Helius-medical-technologies-inc
Helius-medical-technologies
Get-free-report
Medical-technologies
Helius-medical
Free-report
Portable-neuromodulation-stimulator
Helius-medical-technologies-daily
Nasdaq-hsdt

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.